Exercise Strategy for Cancer Survivors
(ACCESS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how a structured 12-week exercise program can improve the physical and psychological well-being of cancer survivors. The researchers seek to determine if regular exercise can reduce the risk of cancer recurrence, lessen treatment side effects such as anxiety and pain, and enhance overall quality of life. Individuals diagnosed with cancer, currently undergoing treatment, or treated within the last five years, who can handle mild physical activity, might be suitable candidates. Participants must be willing to attend the exercise sessions in Halifax.
As an unphased trial, this study offers an opportunity to contribute to valuable research that could enhance recovery and quality of life for cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise strategy is safe for cancer survivors?
Research has shown that exercise is generally safe for cancer survivors. Studies indicate that physical activity can lessen the side effects of cancer treatments. Exercise also reduces fatigue and improves the overall quality of life for cancer survivors. Importantly, staying active can lower the risk of cancer recurrence and may even reduce the chance of dying from cancer. Overall, most cancer survivors tolerate exercise well, making it a safe option to consider.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential benefits of exercise as a unique strategy for cancer survivors. Unlike conventional treatments that may focus solely on medications or therapies targeting cancer cells, this approach emphasizes a 12-week exercise program aimed at improving overall health and quality of life. Exercise can enhance physical fitness, reduce fatigue, and boost mood, offering a holistic benefit that complements existing cancer care. This trial could uncover new insights into how structured physical activity might support long-term recovery and well-being for cancer survivors.
What evidence suggests that exercise is effective for cancer survivors?
Research shows that exercise benefits cancer survivors. In this trial, participants will join a 12-week exercise program called ACCESS. Studies have found that exercise can lower the risk of cancer recurrence and reduce mortality rates. For example, a structured exercise program improved survival rates, with one study showing an 80% disease-free survival rate compared to 74% in those who only received health education. Exercise also reduces side effects of cancer treatments, such as fatigue, anxiety, and depression. Overall, exercise enhances physical fitness and quality of life for cancer survivors.13456
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have been diagnosed with cancer, whether they're about to start treatment, currently in treatment, or finished within the last 5 years. Participants should be able to do light exercise and commit to a 12-week program in Halifax.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline physical fitness testing and cancer-specific screening measures are conducted to determine appropriateness for hospital or community-based physical activity participation
Treatment
Participants engage in a 12-week exercise program including aerobic, resistance, balance, and flexibility exercises delivered in a circuit-type class setting or group/individual personal training format
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, post-intervention, 6 and 12 month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor